Peanut Butter alternative

WOWBUTTER.com - SAFE4SCHOOL WOWBUTTER (soybutter) - Peanut Butter Replacement

FAAN e-Discount Place - FAAN

Check out the discounts offered on allergy friendly products.

FAAN e-Discount Place - FAAN

AAD: Atopic Dermatitis Precursor for Food Allergies --Doctors Lounge

Food allergies? 7 tips for safely celebrating Valentine's Day at School

Dum Dum Lollipop Allergen Info

A Spangler representative confirmed that the information on their website was outdated and has now been updated to reflect accurate information. They also shared the following information with us:

Four years ago, Dum Dums lollipops with a bubble gum and chewy center were manufactured in Brazil. This bubble gum lollipop was discontinued a couple of years ago as we started to manufacture these products in Bryan, Ohio. Since then, we have been manufacturing all Dum Dum lollipops at our facility in Bryan, Ohio USA. In Bryan, there are no problems with the allergens caused by tree nuts, peanuts, wheat gluten, milk, eggs or soy.

Even though we have stopped the importing of the Dum Dum chewy pops from Brazil, we cannot completely guarantee that there is none left in the marketplace. However, the bag will state where the product is manufactured.

Here is an important observation concerning chewy lollipops that have been removed from the bag:

If the chewy Dum Dum has a PAPER STICK, it is manufactured in the USA and free of allergens.
If the chewy Dum Dum has a PLASTIC STICK, it is manufactured in Brazil and has been in a plant with peanut/milk allergens.

Allergy Free Candy | Allergen Free Candy | Allergy Free Bulk Candy

ELL Offers Online Training

Online Training for Food Allergic Families – Special pricing for a limited time only

Parents, grandparents, caregivers and family friends can participate in this comprehensive online training program developed in collaboration with leading experts in allergy & immunology for just $29.95 for a limited time. Modules include a medical review of food allergies along with educational units presented by the ELL Foundation leadership team including the following:
The Need for Food Allergy Safety Training

Creating a Safer Environment for Food Allergic Children

Protect – A comprehensive review of the primary risk areas to food allergic children
Allergic – Understanding food allergies, recognizing signs/symptoms and a review of the leading hypotheses supporting the dramatic rise in food allergy diagnoses
Children – A review of optional protocols and procedures to protect food allergic children through the development of food allergy safety guidelines

Food Preparation Options for a Food Allergic Family
Assessing Psycho-Social Health Among Food Allergic Children
Preparing to Enroll a Food Allergic Child in School
Food Allergy Resources
Risk Assessment Worksheet (RAW): A tool to assist in creating a “family specific” set of food allergy safety guidelines

Following the completion of the online training session, participants will receive an electronic version of the presentation modules, supporting worksheets and tools. For a limited time only, a special, discounted rate of $29.95 will be offered to those who register by February 15th, 2011. ClickHERE or contact contact us directly HERE for more information.Online Training for Families of Food Allergic Children | ELL, Inc.

Peanut Allergy Clinical Trial

The following clinical trial is recruiting participants nationally. FAI is providing information about this study as a service to our constituents.

Study PEP01.09 : Investigational New Drug for Peanut Allergy Using a Skin Delivery SystemResearch sites across the US are looking for a specific category of subjects to complete a research study of the safety and tolerability of an investigational new drug using a skin delivery system for those with a peanut allergy. To qualify, participants must:

Be between the ages of 18 and 50 years
Have a physician-diagnosed or a well-documented history of peanut allergy
Have experienced some severe reactions to peanuts including for example difficulty swallowing, wheezing, feeling of "pending doom," drop of blood pressure, loss of consciousness.

Additional study criteria will be reviewed with study staff at the first study visit.

The study lasts approximately 6 weeks and requires 7 study visits. Participants will receive study-related visits, study-related medical evaluations, and an EpiPen at no cost, plus compensation for time and travel.

Research sites are: Duke University Medical Center, Durham, NC; The National Jewish Medical & Research Center, Denver, CO; Arkansas Children's Hospital Research Institute, Little Rock, AR; Aspen CR, Orem, UT; and CRI Worldwide, Willingboro, NJ.

Find out if you may qualify by contacting:1-877-41-ALLERGY (1-877-412-5537) or visit www.peanutallergytrial.com